Current market catalysts

Fed's Hammack, On Bloomberg, Says Inflation Will End Year Around 3%, Not Meeting Target; Does Not See Restricive Financial Conditions; It's Time For Fed To Act With Rate Hikes, Waiting Will Create Pain; Communicating Fed Issues To Public Is Part Of The Job; Markets Complement The Fed But Aren't Substitute For Fed; Fed Credibility Depends On Delivering On Dual Mandate; There Is Not Much Restriction In The Economy Right Now

-Bloomberg TV.

Dollar General Analysts Boost Their Forecasts After Upbeat Q2 Results

Dollar General (DG) reports strong Q2 results, beats earnings and revenue estimates, raises FY26 guidance above expectations. Shares rise 1.2% pre-market. Analysts raise price targets.

Bernstein Maintains Outperform on Burlington Stores, Lowers Price Target to $355

Bernstein analyst Aneesha Sherman maintains Burlington Stores (NYSE:BURL) with a Outperform and lowers the price target from $365 to $355.

U.S. Patriot Missile Stocks In Europe Are Beyond Critical Due To Iran War, Officials Say, AP Correspondent Lisa Mascaro Says

https://x.com/LisaMascaro/status/2093323357508850127

Guggenheim Maintains Buy on Rubrik, Raises Price Target to $116

Guggenheim analyst John Difucci maintains Rubrik (NYSE:RBRK) with a Buy and raises the price target from $110 to $116.

These Analysts Boost Their Forecasts On Rubrik Following Better-Than-Expected Q2 Results

Rubrik (NYSE:RBRK) beat Q2 expectations with 22 cents/share earnings and $427.26 million revenue. CEO states new AI models have transformed cybersecurity. Analysts raise price targets.

Guggenheim Maintains Buy on Autodesk, Raises Price Target to $283

Guggenheim analyst Tamjid Chowdhury maintains Autodesk (NASDAQ:ADSK) with a Buy and raises the price target from $277 to $283.

What's Going On With Autodesk Shares Friday?

Autodesk shares are trading lower Friday after it reported Q2 results post-market Thursday and issued Q3 EPS guidance below estimates.

Lucas GC Announces 1-For-125 Reverse Stock Split Of Class A And Class B Ordinary Shares Effective September 1, Revised From Previously Set 1-For-80 Ratio

Guggenheim Maintains Buy on Elastic, Raises Price Target to $120

Guggenheim analyst Howard Ma maintains Elastic (NYSE:ESTC) with a Buy and raises the price target from $106 to $120.

Cyabra Receives Six-Figure Contract From Undisclosed Entertainment And Gaming Firm To Oversee Inauthentic Activity

Cyabra, Inc. (NASDAQ:CYAB) ("Cyabra" or the "Company"), an artificial intelligence ("AI")-powered platform that helps governments and enterprises detect coordinated manipulation and protect

Gap Scores Highs As Namesake Brand Delivers Double-Digit Growth

Gap beats Q2 EPS estimates and raises FY26 guidance, while strong Gap brand growth offsets weakness at Old Navy and Athleta.

Guggenheim Maintains Buy on Best Buy Co, Raises Price Target to $95

Guggenheim analyst Steven Forbes maintains Best Buy Co (NYSE:BBY) with a Buy and raises the price target from $90 to $95.

SentinelOne Analysts Increase Their Forecasts After Q2 Results

SentinelOne (NYSE:S) reported strong Q2 results but lowered FY27 EPS guidance. Analysts maintain Buy ratings with price targets ranging from $25-$26.

8-K filing — Allegro Merger Corp.

Filed: 2026-08-28 AccNo: 0001213900-26-094696 Size: 309 KB Item 1.02: Termination of a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

Trading Halt: Halt status updated at 9:00:00 AM ET: Quotation Resumption: News and Resumption Times

Deutsche Bank Initiates Coverage On Rhythm Pharmaceuticals with Hold Rating, Announces Price Target of $120

Deutsche Bank analyst David Hoang initiates coverage on Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Hold rating and announces Price Target of $120.

8-K/A filing — Fidelity Core Real Estate Fund

Filed: 2026-08-28 AccNo: 0001193125-26-372412 Size: 7 MB Item 9.01: Financial Statements and Exhibits

'Grand Theft Auto 6 preview signals blockbuster demand, analysts say' - CNBC

https://x.com/CNBC/status/2093321237036491037

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

These Analysts Increase Their Forecasts On Affirm Following Strong Q4 Results

Affirm Holdings Inc (NASDAQ: AFRM) reported strong fourth-quarter results and expects higher revenue for the first quarter. Analysts have raised price targets for AFRM stock.

Guggenheim Maintains Buy on Revolution Medicines, Raises Price Target to $275

Guggenheim analyst Michael Schmitz maintains Revolution Medicines (NASDAQ:RVMD) with a Buy and raises the price target from $240 to $275.

Citizens Maintains Market Outperform on SentinelOne, Raises Price Target to $25

Citizens analyst Rustam Kanga maintains SentinelOne (NYSE:S) with a Market Outperform and raises the price target from $23 to $25.

Top 3 Industrials Stocks That May Fall Off A Cliff In August

As of Aug. 28, 2026, 3 industrial stocks may warn momentum-seeking investors. RSI compares strength on up/down days to predict short-term performance.

Apple Defies Steepest-Ever Smartphone Slump, iOS Share On Track For Record High: IDC

Apple, Samsung and Huawei's pricing power give them more flexibility in the structurally higher-cost smartphone market.

Keybanc Maintains Overweight on Rubrik, Raises Price Target to $120

Antelope Enterprise Holdings Announces $18.99M Private Placement Of 15M Class A Ordinary Shares At $1.266/Share With Warrants For 15M Shares At $0.50/Share; Expects Close In Q3 2026

Change Agents Joins Seagate Partner Program To Advance AI-Enabled Autonomous Defense Technologies

BMO Capital Maintains Market Perform on DTE Energy, Lowers Price Target to $143

Vivos Therapeutics Announces Definitive Collaboration And Operating Agreements With South Palm Cardiovascular Associates To Form AIM Florida, Where It Expects 75% Interest; Palm Beach County Sleep Center Expected To Begin Treating Patients In Q1 2027